Miaa-376
MIAA‑376 is the product of a target‑focused drug discovery pipeline that started with a genetic hit (MIA‑A) and ended with a clinically viable small molecule.
Studies have shown that MIAA-376 can bind to and inhibit the activity of BCL-2, leading to an increase in apoptosis in certain cancer cells. This suggests that MIAA-376 may have potential as a therapeutic agent for the treatment of cancers that are characterized by overexpression of BCL-2. MIAA-376
Related search suggestions will be provided. MIAA‑376 is the product of a target‑focused drug
Another angle: MIAA could stand for Massachusetts Interscholastic Athletic Association, but then 376 might be a specific event or rule. Or maybe it's a legal case, a product, or a technical document. or a technical document.